Webnavigation search Chanda Macias, Ph.D. MBA, is a cannabis entrepreneur, multi-state operator, and the Founder of National Holistic Healing Center and Ilera Holistic Healthcare [1] medical marijuana dispensaries located in Washington, D.C. … WebDr. Chanda Macias, MBA, is the CEO of Ilera Holistic Healthcare, the medical marijuana cultivator and processor for the state of Louisiana; CEO of National Holistic™ Healing Center (NHHC), the leading medical marijuana dispensary in Washington DC; and Chairwoman of the Board of Managers and CEO for Women Grow, the global leader in …
Historically Black University Launches Its Own CBD Line ... - Forbes
Web2 aug. 2024 · Ilera's cultivation and processing facility in Waterfall, PA includes a genetic library of over 170 cannabis strains, a state-of-the-art greenhouse designed for optimal plant growth and minimal... Web14 jan. 2024 · Build relationships with community partners, advocate the value of medical cannabis, and educate… Part Owner of Ilera Holistic … petco lynnwood wa
Medical Cannabis is Working for Children with Autism - Leafwell
Web18 okt. 2024 · Zelda Therapeutics Limited (ASX: ZLD, OTCQB: ZLDAF) (“Zelda”) is pleased to announce a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics), a privately held medicinal cannabis and cannabinoid science company based in the United States. Subject to approval from Zelda shareholders, and all conditions of sale being met ... Web3 jul. 2024 · The Southern University System's Southern University Agricultural Research and Extension Center is working with Ilera Holistic Healthcare to launch its own THC medical cannabis products. The brand, AYO, is centered on helping patients better manage their medical issues and experience a better quality of life. Web9 okt. 2024 · Zelira. The merger between Zelda and Ilera Therapeutics will create a global medical cannabis company, which will be renamed Zelira Therapeutics Limited (“Zelira”). The merger brings together a portfolio of revenue generating medicines and products undergoing clinical development that are expected to enter the market from 2024. starch house lane playing fields